Lorenzo Consoli is the Founder and CEO of NuvoAir, a leading specialty care provider that delivers a virtual first care model that combines personalized care with proactive monitoring technology and a multidisciplinary team to improve outcomes for people living with heart and lung conditions. Prior to NuvoAir, Lorenzo led and successfully exited a gluten-free startup in Italy. He completed his MBA at Wharton and joined Novartis in Switzerland where he worked in the digital health division, gaining in-depth knowledge on the complexities and deficiencies of respiratory health in Europe and the US. Initially founding NuvoAir with a focus on the European market, in 2021, Lorenzo moved the company’s headquarters to Boston to expand operations in the U.S.
COPD is the sixth leading cause of death—but more than 50% of those impacted don’t even have a diagnosis. The so-called silent epidemic demands urgent action, as exorbitant costs and preventable deaths skyrocket. This four-point plan outlines a holistic strategy to address COPD.